September 7, 2026
Israel is taking a measured step toward the next generation of digital medicine. The Israel Innovation Authority and the Ministry of Health have selected three health-technology companies for a new regulatory sandbox focused on artificial intelligence in healthcare.
The selected projects involve autonomous AI systems for pregnancy care, heart-failure management, and home ultrasound. The program is designed to let developers evaluate and validate advanced medical technologies in a supervised environment while regulators help shape appropriate pathways for future deployment.
That combination of innovation and oversight is important. Medical AI can help clinicians identify risks, support monitoring outside hospitals, and extend access to specialized services. But systems that influence health decisions must be tested carefully, evaluated for reliability, and integrated with professional medical judgment. A regulatory sandbox can create space for experimentation without treating patient safety as an afterthought.
Israel’s strength in technology is most meaningful when it improves people’s lives. Health innovation has the potential to serve patients far beyond Israel’s borders, particularly where distance, staffing shortages, or limited access to specialists make care difficult. The success of these projects will ultimately depend on evidence: whether they are safe, effective, accessible, and useful in real clinical settings.
For friends of Israel, this is an encouraging example of the country’s contribution to global problem-solving. The same society that must devote substantial resources to security continues to invest in research and technologies with the potential to benefit families everywhere.